WallStreetZenWallStreetZen

NASDAQ: ENVB
Enveric Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for ENVB

Based on 1 analyst offering 12 month price targets for Enveric Biosciences Inc.
Min Forecast
$10.00+900%
Avg Forecast
$10.00+900%
Max Forecast
$10.00+900%

Should I buy or sell ENVB stock?

Based on 1 analyst offering ratings for Enveric Biosciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ENVB stock forecasts and price targets.

ENVB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-30

1 of 1

Forecast return on equity

Is ENVB forecast to generate an efficient return?

Forecast return on assets

Is ENVB forecast to generate an efficient return on assets?

ENVB revenue forecast

What is ENVB's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.0M
Avg 2 year Forecast
$10.0M
Avg 3 year Forecast
$15.0M

ENVB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENVB$1.00$10.00+900.00%Buy
XRTX$3.70$14.00+278.38%Strong Buy
EIGR$5.01N/AN/A
CELZ$5.21N/AN/A
KTTA$7.25N/AN/A

Enveric Biosciences Stock Forecast FAQ

Is Enveric Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ENVB) stock is to Buy ENVB stock.

Out of 1 analyst, 0 (0%) are recommending ENVB as a Strong Buy, 1 (100%) are recommending ENVB as a Buy, 0 (0%) are recommending ENVB as a Hold, 0 (0%) are recommending ENVB as a Sell, and 0 (0%) are recommending ENVB as a Strong Sell.

If you're new to stock investing, here's how to buy Enveric Biosciences stock.

What is ENVB's revenue growth forecast for 2025-2027?

(NASDAQ: ENVB) Enveric Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Enveric Biosciences's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ENVB's revenue for 2025 to be $72,940,050, with the lowest ENVB revenue forecast at $72,940,050, and the highest ENVB revenue forecast at $72,940,050. On average, 1 Wall Street analysts forecast ENVB's revenue for 2026 to be $72,940,050, with the lowest ENVB revenue forecast at $72,940,050, and the highest ENVB revenue forecast at $72,940,050.

In 2027, ENVB is forecast to generate $109,410,075 in revenue, with the lowest revenue forecast at $109,410,075 and the highest revenue forecast at $109,410,075.

What is ENVB's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ENVB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ENVB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ENVB price target, the average ENVB price target is $10.00, with the highest ENVB stock price forecast at $10.00 and the lowest ENVB stock price forecast at $10.00.

The Wall Street analyst predicted that Enveric Biosciences's share price could reach $10.00 by Jan 30, 2025. The average Enveric Biosciences stock price prediction forecasts a potential upside of 900% from the current ENVB share price of $1.00.

What is ENVB's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ENVB) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.